Previous news Approval received to run Clinical Phase 1 Trial with Foxy-5 for metastatic breast-, colorectal- and prostate cancers 2013-05-27 Swedish English Improves liquidity with SEK 2.1 million through the sale of 177.500 shares 2013-05-27 Swedish English Notice of annual general meeting and authorization form 2013-05-21 Swedish only Last trading day for BTA 2013-04-17 Swedish only Successful emission was subscribed to 165% 2013-03-27 |